SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Cullinan Therapeutics, Inc. CGEM NASDAQ

NASDAQ Global Select • Healthcare • Medical - Pharmaceuticals • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Cullinan Therapeutics, Inc. (CGEM) has 12 identified peers for comparison in the Healthcare sector. Peers include ACET, AUTL, BOLT, CCCC, DAWN, EWTX and others.

CGEM has a market capitalization of $904.87M, compared to an average peer market cap of $955.6M.

Peers & Similar Companies — CGEM

Adicet Bio, Inc.

$7.92 +13.14% $76.03M

Autolus Therapeutics plc

$1.49 +0.68% $396.55M

Bolt Biotherapeutics, Inc.

$4.91 +3.59% $9.43M

C4 Therapeutics, Inc.

$2.89 +4.90% $239.37M

Day One Biopharmaceuticals, Inc.

$21.47 +0.05% $2.22B

Edgewise Therapeutics, Inc.

$33.70 +1.63% $3.62B

Monte Rosa Therapeutics, Inc.

$18.23 +4.17% $1.19B

Century Therapeutics, Inc.

$2.59 +9.28% $224.21M

aTyr Pharma, Inc.

$14.77 +0.54% $928.41M

Lyell Immunopharma, Inc.

$23.84 +2.01% $555.64M

Lyra Therapeutics, Inc.

$0.44 -11.98% $781.13K

Mineralys Therapeutics, Inc.

$30.42 +11.35% $2.02B

People Also View

Revolution Medicines, Inc.

Edgewise Therapeutics, Inc.

Day One Biopharmaceuticals, Inc.

Mineralys Therapeutics, Inc.

Olema Pharmaceuticals, Inc.

Monte Rosa Therapeutics, Inc.

aTyr Pharma, Inc.

Sana Biotechnology, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message